Two Intensities of Transcranial Direct Current Stimulation to Improve Consciousness in Severely Brain Injured Patients

NCT ID: NCT03007784

Last Updated: 2017-01-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE3

Total Enrollment

300 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Limited treatments are available to improve consciousness in severely brain injured patients. Transcranial Direct Current stimulation (tDCS) is one of the few therapeutics that showed evidence of efficacy to increase level of consciousness and functional communication in some minimally conscious state (MCS) patients, and in some vegetative state (VS) patients. However the optimal intensity of electrical current stimulation remains unknown.

This study will test the effects of two intensities of tDCS stimulation (either 0.2mA or 2mA) applied on left dorso-lateral prefrontal cortex on both behavior, - assessed by the Coma Recovery Scale-Revised (CRS-R) scores -, as well as quantified EEG recorded during resting state (using algorithms previously designed and published by the investigators) and event-related potentials (using auditory paradigms we previously published) in severely brain damaged patients with disorders of consciousness (MCS, VS, and conscious but cognitively disabled patients) of various etiologies.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will use a cross-over double-blind design with each patient receiving both current intensities in a randomized order during 4 weeks (2 weeks for each tDCS intensity, totalizing a number of 10X2 stimulation sessions of 20 minutes each).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Disorder of Consciousness Minimally Conscious State Vegetative State Cognitive Impairment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

2 mA anodal tDCS stimulation

Anodal tDCS stimulation at 2 mA applied to the left dorsolateral prefrontal during 20 minutes five days a week for two consecutive weeks

Group Type EXPERIMENTAL

transcranial direct current stimulation (tDCS) / Comparison of current intensities

Intervention Type DEVICE

0.2 mA anodal tDCS stimulation

Anodal tDCS stimulation at 0.2 mA applied to the left dorsolateral prefrontal during 20 minutes five days a week for two consecutive weeks

Group Type ACTIVE_COMPARATOR

transcranial direct current stimulation (tDCS) / Comparison of current intensities

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

transcranial direct current stimulation (tDCS) / Comparison of current intensities

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Non communicative patients (including conscious patients but presenting with major fluctuations of vigilance and/or of cognitive abilities)
* Patients with stable clinical examination
* Age between 18 and 80 years
* Brain injury confirmed by cerebral imaging (MRI or TDM)
* Disorder of consciousness diagnosed by CRS-R (VS, MCS, exitMCS)

Exclusion Criteria

* Status epilepticus
* Severely neurodegenerative illnesses (Alzheimer disease, Lewy Body Dementia)
* Pregnancy
* Patients underage
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hôpital Raymond Poincaré

OTHER

Sponsor Role collaborator

Hospices Civils de Lyon

OTHER

Sponsor Role collaborator

Groupe Hospitalier Pitie-Salpetriere

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

LIONEL NACCACHE

MD, PhD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lionel Naccache, MD PhD

Role: STUDY_DIRECTOR

Paris 6 University ICM Inserm APHP

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Groupe Hospitalier Pitié-Salpêtrière

Paris, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jacobo Sitt, MD PhD

Role: CONTACT

+33 1 57 27 43 17

Bertrand Hermann, MD Msc

Role: CONTACT

+33 1 57 27 43 14

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Lionel Naccache, MD, PhD

Role: primary

+33157274314

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SC20160427

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.